Last updated on January 2010

Newly Diagnosed Mantle Cell Lymphoma who are not eligible for a bone marrow transplant.


Brief description of study

Newly Diagnosed Mantle Cell Lymphoma who are not eligible for a bone marrow transplant.

Detailed Study Description

Newly Diagnosed Mantle Cell Lymphoma who are not eligible for a bone marrow transplant.

Patient Inclusion Criteria:

  • 18 + years of age,
  • diagnosis of MCL, at least 1 measurable site of disease, not eligible or not considered for bone marrow transplantation

Patient Exclusion Criteria:

  • Prior treatment with VELCADE, major surgery with 2 weeks before randomization, peripheral neuropathy or neuropathic pain, diagnosed or treated for a malignancy other than MCL within 1 year of randomization

Clinical Study Identifier: TX134730

Find a site near you

Start Over

Legacy Pharma Research

601 N. 5th St. Bismarck, ND USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.